{"name":"Igenica Biotherapeutics, Inc.","slug":"igenica-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IGN523","genericName":"IGN523","slug":"ign523","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"IGN523","genericName":"IGN523","slug":"ign523","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOMHBVcjRJWWVsOVFrZC1sT1N2eHQ5c0g5ZEdEcjNFakt5MEcyV0s3YVZhVzVzbjJfcHdTWm5IMl9ZbGZMYWF5cUkxR2xscmVGc3dwTXkwVk51U0tQbnJMMjBEdEM3TGY1RTMyZWdJOWo0a2hrVjJxeXhhS1VMZEVsa0R4ZWJPY2FkcHQtVFJuS2lMMVJ1VDAyZGlIOEgxb3ZySzNvNFRIck8tcVBnd2c?oc=5","date":"2023-10-24","type":"pipeline","source":"The Business Journals","summary":"Rockville cancer therapy firm Sensei Biotherapeutics faces delisting threat from Nasdaq - The Business Journals","headline":"Rockville cancer therapy firm Sensei Biotherapeutics faces delisting threat from Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOVU9sTTVSLXZvQl9PNzV1N2RKNzBXMkJOcU5XVHZWbjJHakJFVXNkUk54YW1ySE92NFlsRTJ6eDdoRnJvWUJGUUk3cV8yN0FPZkZ3bXhnbnFVSTNPNmVLWXpxMmxyZHQ3WkNZLUtCWmlMcFdZMm5GRkY1SEVLUGhUYmpjcy13TGQ3UUM1c3lpMjFnbGNJUkN0N3kyeDMzMHc?oc=5","date":"2018-05-16","type":"pipeline","source":"fiercebiotech.com","summary":"Panacea, renamed as Sensei Bio, appoints former X4 executive as CEO - fiercebiotech.com","headline":"Panacea, renamed as Sensei Bio, appoints former X4 executive as CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOTEFDLU5xb0FjekF1M1hpRWVqM0QtNlV6c2JDa3kxZWFiSzREbEo1bjNvRzlQbG1SaHBlWGk1TVA3NHpOZXNMNXBSSzhKWi1HSjVsSDFHX3dxWHBOQUZFTnhBY1FBbDE1X2Q3ZmFteWhIWlV0bDZLSFU3cjU4d0QzWFlKMTFSWEp2ZlBsVktMeng?oc=5","date":"2017-05-24","type":"deal","source":"fiercebiotech.com","summary":"Pierre Fabre buys up Igenica preclinical I-O meds - fiercebiotech.com","headline":"Pierre Fabre buys up Igenica preclinical I-O meds","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}